Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × Cytarabine × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 126 Precursor Cell Lymphoblastic Leukemia-Lymphoma 49 Leukemia 26 Burkitt Lymphoma 26 Myelodysplastic Syndromes 25 Leukemia, Biphenotypic, Acute 21 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 15 Recurrence 14 Lymphoma, Mantle-Cell 13 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, Non-Hodgkin 9 Lymphoma 9 Leukemia, Myelomonocytic, Chronic 9 Myeloproliferative Disorders 8 Lymphoma, Large B-Cell, Diffuse 8 Neoplasm, Residual 6 Leukemia, Monocytic, Acute 5 Hodgkin Disease 5 Hematologic Neoplasms 5 Down Syndrome 5 Blast Crisis 5 Sarcoma, Myeloid 4 Lymphoma, T-Cell 4 Lymphoma, Follicular 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Myelomonocytic, Juvenile 3 Leukemia, Myeloid, Accelerated Phase 3 Multiple Myeloma 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2

Interventions

Cyclophosphamide 7 Rituximab 5 fludarabine 4 Vincristine 4 Prednisone 4 Doxorubicin 4 fludarabine phosphate 3 Tacrolimus 3 Mycophenolic Acid 3 Etoposide 3 Busulfan 3 venetoclax 2 entrectinib 2 atezolizumab 2 alectinib 2 acalabrutinib 2 Whole-Body Irradiation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Bortezomib 2 trametinib 1 pertuzumab 1 obinutuzumab 1 liposomal doxorubicin 1 isatuximab 1 ibrutinib 1 etoposide phosphate 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡